This study will assess the efficacy of Cellular MatrixTM BCT-HA Kit treatment compared to placebo condition on revitalization and skin rejuvenation on the midface. Particular attention will be made to the safety aspects, as well as the histological consequences of treatment.
Age range
30 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in Skin Quality Rating Scale
Timeframe: Week 32
Change in Global Aesthetic Improvement Scale
Timeframe: Week 32
Change in FACE-Q Score
Timeframe: Week 32
Physician's Global assessment to measure quality of life
Timeframe: 4 weeks after treatment 1st, 2nd and 3rd treatments and 32 weeks after enrollment
Visual Analog Score for patients
Timeframe: Immediately after 1st, 2nd and 3rd treatments
Wrinkle assessment
Timeframe: Week 32